Scottsdale, AZ (PRWEB) April 22, 2014
Scottsdale, Arizona-based Diamondback Drugs is pleased to announce the initiation of its 2014 Veterinary Cancer Society Case Report Competition. Veterinary oncology residents will compete for a $1,000 grand prize, to be used to cover expenses incurred while attending the annual Veterinary Cancer Society conference.
This year’s VCS conference will take place in beautiful St. Louis, MO. The event is an ideal forum for gathering professional knowledge, getting a glimpse of the latest innovations, and networking with peers and potential mentors in the veterinary oncology field.
Diamondback Drugs, a compounding pharmacy specializing in veterinary medicine, holds a number of scholarship competitions aimed at illuminating up-and-coming veterinary students and residents on the utility and advantages of prescription compounding, which is the pharmacy’s central field of expertise.
Diamondback Drugs has been in veterinary pharmaceuticals long enough to have seen the field grow, advance, and change quite significantly. The company recognizes that recent graduates and residents will play crucial parts in molding the future of the profession, and in improving therapeutic outcomes.
Veterinary medicine is a field wherein new innovations come at a rapid pace, so one cannot understate the value of the years of practical experience possessed by the profession’s established specialists. There’s no denying that today’s crop of new veterinary oncology residents will take on important roles in shaping the future of the discipline.
Last year’s VCS Case Study Competition winner, Jeanne Larson, offered a gripping account of the story of Molly, a golden retriever that was diagnosed with lymphoma and given 6 months to live. Molly’s devoted owners weren’t content to accept the prognosis, and vowed to do everything in their power to extend Molly’s time on earth while improving her quality of life.
Despite the grim forecast, Molly’s second round of treatment resulted in strong improvements, but the medication that had proven so efficacious suddenly became impossible to source from the previous supplier. Fortunately, Diamondback Drugs was able to custom-compound the scarce medication and ship it to Molly’s home, where it proved quite effective in combatting her affliction.
Last year’s VCS competition winner set a high bar, but Diamondback Drugs is confident that there are plenty of veterinary oncology residents with equally compelling case studies to share. The company wishes this year’s field of entrants the best of luck.
Get Application and Competition Information: VCS 2014 Competition
About Diamondback Drugs
Scottsdale, Arizona-based Diamondback Drugs specializes in the art and science of veterinary compounding. They offer home delivery, and stock the widest range of medications, chemicals, bases and flavors. Learn more about Diamondback Drugs at their website: http://www.diamondbackdrugs.com/ or call them direct at 866-578-4420.